What Isn’t Included in the Recent Exemption
November 27, 2024

What Isn’t Included in the Recent Exemption

Who Does It Apply To? Recently, I shared that eligible trading partners were temporarily exempted from specific components of the Drug Supply Chain Security Act, “Latest DSCSA Exemption”. However, considering the stabilization period ends tomorrow, I thought I’d share some further insights on what isn’t part of the recent exemption. First, as noted in my […]
Read More
So, You Think You’re Exempt
November 22, 2024

So, You Think You’re Exempt

DSCSA Deadline: Just Days Away The deadline for DSCSA stabilization is just days away, mandating Enhanced Drug Distribution Security (EDDS) requirements for manufacturers, repackagers, wholesale distributors, and dispensers. While the FDA announced an extension from certain components of the FD&C in the form of a phased approach, this extension only applies to certain eligible trading […]
Read More
What Is Exempt, per recent DSCSA Update 
November 22, 2024

What Is Exempt, per recent DSCSA Update 

According to the DSCSA Exemption Announcement from the FDA on October 9th, here are the specific components of the legislation that eligible trading partners are exempt from.  Section 582(g)(1)(A-F) for Manufacturers and Repackagers, Wholesale distributors, and Dispensers  ‘‘(A) The transaction information and the transaction statements as required under this section shall be exchanged in a […]
Read More
Verification Router Services: A Solution to Drug Shortages? 
November 8, 2024

Verification Router Services: A Solution to Drug Shortages? 

The Importance of Collaboration to Address Drug Shortages On October 31st, 2024, I listened to a compelling LinkedIn conversation hosted by Chip Davis of the Healthcare Distribution Alliance, titled “Working Collaboratively to End Drug Shortages.” Joined by Laura Bray of Angels for Change and April Gile of the End Drug Shortages Alliance (EDSA), the panelists […]
Read More
Revisiting Florida’s Plan to Import Drugs from Canada
October 23, 2024

Revisiting Florida’s Plan to Import Drugs from Canada

An FDA-Approved Plan with Major Implications Earlier this year, the FDA authorized Florida’s proposal to import select drugs from Canada under section 804 of the FD&C Act. The law allows companies to import prescription drugs in bulk if doing so saves Americans money and doesn’t put the health and safety of Americans at risk. According […]
Read More